F320-0355 Screening compound: 1-[4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]-N-{4-[(piperidin-1-yl)methyl]phenyl}piperidine-4-carboxamide

F320-0355 Screening compound: 1-[4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]-N-{4-[(piperidin-1-yl)methyl]phenyl}piperidine-4-carboxamide
F320-0355 Screening compound: 1-[4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]-N-{4-[(piperidin-1-yl)methyl]phenyl}piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F320-0355
1-[4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]-N-{4-[(piperidin-1-yl)methyl]phenyl}piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F320-0355

Molecular Formula

C28H33N5O3 (C28 H33 N5 O3)

Compound Name

1-[4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]-N-{4-[(piperidin-1-yl)methyl]phenyl}piperidine-4-carboxamide

IUPAC name

1-[4-(5-methyl-124-oxadiazol-3-yl)benzoyl]-N-{4-[(piperidin-1-yl)methyl]phenyl}piperidine-4-carboxamide

SMILES

Cc1nc(-c(cc2)ccc2C(N(CC2)CCC2C(Nc2ccc(CN3CCCCC3)cc2)=O)=O)no1

InChI

InChI=1S/C28H33N5O3/c1-20-29-26(31-36-20)22-7-9-24(10-8-22)28(35)33-17-13-23(14-18-33)27(34)30-25-11-5-21(6-12-25)19-32-15-3-2-4-16-32/h5-12,23H,2-4,13-19H2,1H3,(H,30,34)

InChI Key

LXUIQERLUDQSJQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27115315

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

487.6

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.198

Distribution Coefficient, logD

1.616

Water Solubility, LogSw

-3.22

Polar Surface Area

74.616

Acid Dissociation Constant (pKa)

11.50

Base Dissociation Constant (pKb)

8.97

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

42.90

F320-0355 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

MCL1 Targeted Library (12200 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Kinases
  • Phosphatases

References: we are preparing a list of scientific research reports with F320-0355 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F320-0355?
Check Price and Availability of F320-0355, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F320-0355 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F320-0355
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F320-0355
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F320-0355 available by request